2nd Annual MarketsandMarkets

Single Cell-Omics Conference

9th - 10th October 2023

Ibis London Earls Court Hotel & ILEC Conference Centre

Scrutinizing the Innovative Research in Single-Cell Omics

The fundamentals of Single Cell have proven to be an indispensable resource in the sphere of medical research and new diagnostic strategies. Recent advances in single cell technologies have opened new opportunities to signify the intra-tumor cell heterogeneity, identify rare cell kinds, degree of mutation, and ultimately guide diagnosis and treatment option.

Omics technologies helps in comprehensive examination of genome biology (Genomics), proteins (Proteomics) and RNA molecules (Transcriptomics) which in turn are used for drug discovery and development. Thus, these single cell omics prospects are much anticipated to revolutionise our adequacy to understand the magnitude of omics diversity occurring in our biological systems.

MarketsandMarkets is delighted to announce its 2nd Annual Single-Cell Omics Conference scheduled to be held on 9th – 10th October 2023 at Ibis London Earls Court Hotel & ILEC Conference Centre. The conference will assimilate diverse sessions on a board prospective of novel research and development in the field of multi-omics research. The event encompasses the Researchers, Scientists from top universities and pharmaceutical companies from all around the globe and provides the platform to share the knowledge with academic peers and present their research papers and reports.

WHAT TO EXPECT

  • Single cell genomic analysis for cancer/cellular heterogeneity
  • Single Cell Transcriptional Profiling, Digital spatial profiling
  • Spatial Single cell genome analysis – Sequencing application
  • Single-Cell phenotyping
  • Application of multiplex imaging – Single cell and tissue imaging
  • Current & Emerging Tools and Data Analysis in Single Cell Omics
  • Single Cell Analysis in Drug Discovery & Development – Sample Preparation and Processing

  • Industry: Pharma/Therapeutic Companies/Start Up’s
  • CEOs, CMO’s, CSO’s, COO’s, Presidents, Vice Presidents, Directors, Managing Directors, Head of Departments, Executive Leaders, Pharmacists, Oncologists, Geneticists, Bioinformatician, Protein Scientist, Principal Scientists, Big Data Scientists, Business Development, Regulatory and Policy Advisors, Diagnostic Laboratory Professionals, Global Leaders
  • Departments: Genomics, Proteomics, Oncology, Molecular Biology, Genetics Bioinformatics, Computational Biology, Protein science, Pharmacogenomics, Biotechnology, Data Science, Microbiologists, Virologists, Pathologists
  • Academics: Universities, Research Institutes, Hospitals
  • Head of Departments, Professors, Lecturers, Senior Scientists, Researchers, Bioinformaticians
  • Departments: Genomics, Proteomics, Oncology, Molecular Biology, Genetics Bioinformatics, Computational Biology, Protein science, Pharmacogenomics, Biotechnology, Data science, Microbiologists, Virologists, Pathologists

  • Witness live action how Single-Cell Omics technology is revolutionizing the future of Biomedical research
  • Quality insights and cohesiveness of key issues with respect to Single-Cell to be addressed
  • Discover the different avenues in application of Multi-Omics studies
  • Comprehend the current and future research avenues of Single-Cell Omics in drug discovery and development
  • Discuss the emerging technologies and opportunities with cutting edge strategies
  • Opportunity for one-on-one networking with the delegates and extend professional competency

CONFERENCE AGENDA

Registration

09:00 - 09:25

Opening remarks by the Chairperson

Monica Raimo

Monica Raimo, Senior Research Manager and Team Lead, Glycostem Therapeutics

09:25 - 09:30

Novel Research in Single-Cell Omics Analysis

Spatial Genomics - Understanding Issues the Hard Way

Nik Matthews

Nik Matthews, Head of the Imperial BRC Genomics Facility, Imperial College London

09:30 - 10:00

Current Landscape of Liquid Biopsies as a Tool for Cancer Diagnosis and Prognosis

Emmanouil Karteris

Emmanouil Karteris, Reader in Biomedical Sciences, Brunel University

10:00 - 10:30

Namocell, Low Pressure Single Cell Dispensing to Improve Cell Viability

Steven Johnstone

Steven Johnstone, Field Applications Scientist, EMEA FAS, Bio-Techne

10:30 - 11:00

Morning Refreshments | One-to-One Networking Meeting

11:00 - 11:40

Protein Quantification from a Single Cell Using TMTpro™ Mass Spectrometry

Illip Burmester

Illip Burmester, Technical and Applications Manager, Proteome Sciences

11:40 - 12:10

Deconvoluting Genetic and Transcriptomic Tumour Heterogeneity Underlying Aggressive ER+ Breast Cancers.

Shefali Thakur

Shefali Thakur, Higher Scientific Officer, The Institute of Cancer Research

12:10 - 12:40

WOLF Microfluidic Sorting Preserves Cell Health, Stemness and Viability

Michal Bonar

Michal Bonar, Distribution Support Manager EMEA, Nanocellect

12:40 - 13:10

Digital spatial profiling Leveraging Multiomics Data to better understand Mechanisms of Resistance to Therapy and Develop Cancer Biomarkers.

Danish Memon

Danish Memon, Lead Bioinformatics Scientist, ThirtyFiveBio

13:10 - 13:40

Lunch and Poster Presentation | One-to-One Networking

13:40 - 14:40

Single-Cell Sequencing in Rare Diseases and our Research is now more focusing on Therapeutics of Rare Diseases: Using Autologous Stem Cell Therapy in the Area of Muscle Diseases, Cancer, and Aging Related Diseases.

Rick Kamps

Rick Kamps, NGS Manager, Maastricht University

14:40 - 15:15

Panel Discussion – ‘’Targeting Tumour Microenvironment for Clinical Outcomes – How far are we?’’

Shefali Thakur

Shefali Thakur, Higher Scientific Officer, The Institute of Cancer Research

Emmanouil Karteris

Emmanouil Karteris, Reader in Biomedical Sciences, Brunel University

Dimitrios A. Lamprou

Dimitrios A. Lamprou, Professor (chair) of Biofabrication and Advanced Manufacturing, Queen’s University Belfast

Danish Memon

Danish Memon, Lead Bioinformatics Scientist, ThirtyFiveBio

Moritz Haneklaus

Moritz Haneklaus, Senior Research Scientist, Macomics

15:15 - 16:00

Evening Refreshments and Poster Presentation | One-to-One Networking

16:00 - 16:40

Using Omics to Advance Macrophage Drug Discovery

Moritz Haneklaus

Moritz Haneklaus, Senior Research Scientist, Macomics

16:40 - 17:15

Closing Remarks from the Chairperson

Monica Raimo

Monica Raimo, Senior Research Manager and Team Lead, Glycostem Therapeutics

17:15 - 17:20

Drinks Reception and Networking

17:20 - 17:20

End of Day 1

17:20 - 17:20

Registration

08:15 - 08:50

Welcome note by MarketsandMarkets

08:50 - 08:55

Opening remarks by the Chairperson

Monica Raimo

Monica Raimo, Senior Research Manager and Team Lead, Glycostem Therapeutics

08:55 - 09:00

Emerging tools and Technologies in Single Cell Omics

Changing Research in Omics Data

Alessandro Riccombeni

Alessandro Riccombeni, CEO and founder, Axia Medicine

09:00 - 09:30

Biophysical Approaches for Live Single Cell Analysis

Stephen Evans

Stephen Evans, Professor, University of Leeds

09:30 - 10:00

Microfluidics for continuous and scalable approaches in nanomedicine

Dimitrios A. Lamprou

Dimitrios A. Lamprou, Professor (chair) of Biofabrication and Advanced Manufacturing, Queen’s University Belfast

10:00 - 10:30

Morning Refreshments and Poster Presentation | One-to-One Networking

10:30 - 11:20

Identification of Signatures of Superior Cytotoxic NK Cells via Bulk and Single-Cell Transcriptomics

Monica Raimo

Monica Raimo, Senior Research Manager and Team Lead, Glycostem Therapeutics

11:20 - 11:55

Single-cell Whole Genome Sequencing to study Somatic CNVs in Human Post-Mortem Brains

Ester Kalef-Ezra

Ester Kalef-Ezra, Postdoctoral Research Fellow, Proukakis Lab, University College London

11:55 - 12:30

How to deal with Single Cell Omics Data in Research, Diagnostics, and Public Health?

Rick Kamps

Rick Kamps, NGS Manager, Maastricht University

12:30 - 13:15

Lunch | One-to-One Networking

13:15 - 14:15

Single Cell Project Design: Fitting the Single Cell Samples to the Technology

Nik Matthews

Nik Matthews, Head of the Imperial BRC Genomics Facility, Imperial College London

14:15 - 14:45

Closing remarks by the Chairperson

Monica Raimo

Monica Raimo, Senior Research Manager and Team Lead, Glycostem Therapeutics

14:45 - 14:50

End of Conference

14:50 - 14:50

SPEAKERS

Emmanouil Karteris

Emmanouil Karteris

Reader in Biomedical Sciences, Brunel University

Steven Johnstone

Steven Johnstone

Field Applications Scientist, EMEA FAS, Bio-Techne

Nik Matthews

Nik Matthews

Head of the Imperial BRC Genomics Facility, Imperial College London

Stephen Evans

Stephen Evans

Professor, University of Leeds

Shefali Thakur

Shefali Thakur

Higher Scientific Officer, The Institute of Cancer Research

Danish Memon

Danish Memon

Lead Bioinformatics Scientist, ThirtyFiveBio

Michal Bonar

Michal Bonar

Distribution Support Manager EMEA, Nanocellect

Alessandro Riccombeni

Alessandro Riccombeni

CEO and founder, Axia Medicine

Dimitrios A. Lamprou

Dimitrios A. Lamprou

Professor (chair) of Biofabrication and Advanced Manufacturing, Queen’s University Belfast

Rick Kamps

Rick Kamps

NGS Manager, Maastricht University

Ester Kalef-Ezra

Ester Kalef-Ezra

Postdoctoral Research Fellow, Proukakis Lab, University College London

Moritz Haneklaus

Moritz Haneklaus

Senior Research Scientist, Macomics

Monica Raimo

Monica Raimo

Senior Research Manager and Team Lead, Glycostem Therapeutics

ENQUIRE NOW

SPONSORS

PARTNERS

LOCATION

Venue

Ibis London Earls Court Hotel & ILEC Conference Centre

PAST EVENT GALLERY